Marshall Wace’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $64.1K | Buy |
+30,400
| New | +$64.1K | ﹤0.01% | 2430 |
|
2024
Q4 | – | Sell |
-52,259
| Closed | -$144K | – | 2531 |
|
2024
Q3 | $144K | Buy |
52,259
+33,434
| +178% | +$91.9K | ﹤0.01% | 2163 |
|
2024
Q2 | $42.5K | Buy |
+18,825
| New | +$42.5K | ﹤0.01% | 2231 |
|
2021
Q3 | – | Sell |
-47,509
| Closed | -$152K | – | 2546 |
|
2021
Q2 | $152K | Buy |
+47,509
| New | +$152K | ﹤0.01% | 1980 |
|